UKNoticeOfficial ✓July 28, 2026· GOV.UK
Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine
What happened
The Court of Appeal has confirmed that firms broke the law by charging excessive and unfair prices for hydrocortisone tablets. This illicit pricing practice spanned "over a decade." The ruling upholds "CMA findings" regarding this misconduct.
Why it matters
This ruling ensures accountability for firms that exploited pricing for "lifesaving NHS-funded medicine." It addresses the financial burden placed on the NHS and potentially impacts future drug pricing regulations.
Who it affects
- ›Firms charged with excessive pricing
- ›Patients needing hydrocortisone tablets
- ›UK justice system
Receipts
The receipts are official. The summary is ours.
Read on GOV.UK ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.
More from UK
UKNoticeOfficial ✓
The United Kingdom has long supported strengthening the UN sanctions regime: UK Explanation of Vote at the UN Security CouncilGOV.UK·Sep 11, 2026
UKBillOfficial ✓
Reforms to welfare system set to save £1.9 billion by the end of 2030/31GOV.UK·Sep 11, 2026
UKNoticeOfficial ✓
The United Kingdom strongly condemns the Houthis’ decision to resume conflict in Yemen and their continued strikes on Saudi Arabia: UK statement at the UN Security CouncilGOV.UK·Sep 10, 2026